Catapult CEOs
Matthew Durdy
CEO of Cell and Gene Therapy Catapult
Matthew has been part of the founding team of Cell and Gene Therapy Catapult since 2012, taking on the post of CEO in 2020. Prior to this, he was Chief Business Officer responsible for the strategy, communications, marketing, and business development.
Martin McHugh
CEO of Compound Semiconductor Applications Catapult
Martin McHugh is Chief Executive of the Compound Semiconductor Applications Catapult driving its approach to accelerate the UK industry’s ability to exploit advancements in compound semiconductor technologies,
Erika Lewis
CEO of Connected Places Catapult
Erika Lewis is Chief Executive at Connected Places Catapult. Erika joined the Catapult from the Department for Science, Innovation and Technology (DSIT) where she was Director, Cyber Security and Digital Identity.
Susan Bowen
CEO of Digital Catapult
As CEO of Digital Catapult, Susan is focused on bringing together her 25+ years of experience in the technology sector to guiding and co-creating an ethical approach to advances in technology across multiple industries with an aim to effectively balance our Digital Catapult initiatives from Research and Development through to commercialisation.
Guy Newey
Chair of the Innovate UK Catapult Network & CEO of Energy Systems Catapult
Guy was appointed Chief Executive Officer at Energy Systems Catapult, the innovation business, in June 2022. Guy joined Energy Systems Catapult in 2018 as Director of Strategy after working as an energy and political adviser to two UK Government Secretaries of State; Greg Clark and Amber Rudd.
Katherine Bennett
CEO of High Value Manufacturing Catapult
As Chief Executive of HVM Catapult, Katherine Bennett is a proud ambassador for UK design, engineering and manufacturing. Katherine drives UK industrial transformation with industry, academia and government to commercialise cutting-edge research and advance national strategic priorities, including clean energy, health tech and key enablers skills, supply chain and sustainable R&D manufacturing
Chris Molloy
CEO of Medicines Discovery Catapult
Chris Molloy has a 30-year international board and executive career across a unique range of life sciences R&D disciplines. His career began in preclinical research at Glaxo, where he was closely involved with the industrialisation of high throughput discovery. In 2004 he moved to Asia as COO of MerLion Pharmaceuticals, a Singaporean biotech that developed into an award-winning multinational anti-infectives R&D biotech.
Andrew Walls
Acting CEO of Offshore Renewable Energy Catapult
Andrew, acting CEO and Director of Professional Services, leads the Catapults Professional Services directorate which includes all enabling & governing services (Finance, HR, ICT, Procurement, Business Improvement / Governance, Administration and Legal services). Having trained with the global Professional Services firm PricewaterhouseCoopers, Andrew worked with both private and public sectors delivering audit, financial diligence and consultancy assignments for the firm in the UK and abroad.
John Abbott
CEO of Satellite Applications Catapult
John Abbott is the new CEO of the Satellite Applications Catapult. He joined the Catapult from the Real Estate Registry in Saudi Arabia, where he was Chief Digital Officer. John was instrumental in the delivery of the Kingdom’s first ever registry of land ownership as part of a public-private partnership supported by the Public Investment Fund.